CIK: 0001425738 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $939,575 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 3,929,039 | $139,167 | 14.8% | $12.18 | +157.7% | COM | 80706P103 |
| KRYS | KRYSTAL BIOTECH INC | 663,471 | $91,201 | 9.7% | $58.73 | +150.1% | COM | 501147102 |
| ZYME | ZYMEWORKS INC | 4,150,627 | $52,090 | 5.5% | $7.05 | +69.0% | COM | 98985Y108 |
| STOK | STOKE THERAPEUTICS INC | 4,375,931 | $49,667 | 5.3% | $9.00 | +5.5% | COM | 86150R107 |
| IMNM | IMMUNOME INC | 4,872,225 | $45,312 | 4.8% | $10.67 | -23.2% | COM | 45257U108 |
| REPL | REPLIMUNE GROUP INC | 4,664,791 | $43,336 | 4.6% | $16.51 | -47.2% | COM | 76029N106 |
| NRIX | NURIX THERAPEUTICS INC | 3,732,888 | $42,518 | 4.5% | $20.56 | -47.4% | COM | 67080M103 |
| LIVN | LIVANOVA PLC | 934,271 | $42,061 | 4.5% | $70.40 | -41.4% | SHS | G5509L101 |
| ADCT | ADC THERAPEUTICS SA | 15,666,731 | $41,987 | 4.5% | $19.52 | -89.2% | SHS | H0036K147 |
| — | AKERO THERAPEUTICS INC | 774,311 | $41,317 | 4.4% | $33.38 | — | COM | 00973Y108 |
| RGNX | REGENXBIO INC | 4,775,717 | $39,209 | 4.2% | $22.74 | -63.2% | COM | 75901B107 |
| KYMR | KYMERA THERAPEUTICS INC | 803,289 | $35,056 | 3.7% | $32.56 | +5.8% | COM | 501575104 |
| BEAM | BEAM THERAPEUTICS INC | 1,423,411 | $24,212 | 2.6% | $26.47 | -34.2% | COM | 07373V105 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $21,211 | 2.3% | $19.01 | -85.2% | COM | 00091E109 |
| NGNE | NEUROGENE INC | 1,276,676 | $19,086 | 2.0% | $21.67 | -27.6% | COM | 64135M105 |
| HNGE | HINGE HEALTH INC | 300,000 | $15,525 | 1.7% | $40.42 | 0.0% | CL A | 433313103 |
| — | 89BIO INC | 1,545,208 | $15,174 | 1.6% | $11.28 | — | COM | 282559103 |
| ANNX | ANNEXON INC | 6,300,644 | $15,122 | 1.6% | $13.35 | -85.0% | COM | 03589W102 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $14,418 | 1.5% | $13.12 | -91.1% | COM | 31189P102 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $12,556 | 1.3% | $18.53 | — | ADS | 82686Q101 |
| COGT | COGENT BIOSCIENCES INC | 1,448,040 | $10,397 | 1.1% | $8.96 | -38.1% | COM | 19240Q201 |
| BHVN | BIOHAVEN LTD | 729,515 | $10,293 | 1.1% | $27.39 | -34.9% | COM | G1110E107 |
| SLDB | SOLID BIOSCIENCES INC | 1,915,926 | $9,331 | 1.0% | $4.65 | -24.0% | COM NEW | 83422E204 |
| BSX | BOSTON SCIENTIFIC CORP | 85,301 | $9,162 | 1.0% | $51.20 | +97.6% | COM | 101137107 |
| IDYA | IDEAYA BIOSCIENCES INC | 432,494 | $9,091 | 1.0% | $29.85 | -35.7% | COM | 45166A102 |
| — | VERVE THERAPEUTICS INC | 740,261 | $8,313 | 0.9% | $34.54 | — | COM | 92539P101 |
| CBLL | CERIBELL INC | 435,239 | $8,152 | 0.9% | $27.25 | -37.6% | COM | 15678C102 |
| KROS | KEROS THERAPEUTICS INC | 552,506 | $7,376 | 0.8% | $59.30 | -77.2% | COM | 492327101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 343,026 | $6,981 | 0.7% | $11.60 | +67.9% | COM NEW | 15117B202 |
| FOLD | AMICUS THERAPEUTICS INC | 1,188,998 | $6,813 | 0.7% | $10.35 | -37.6% | COM | 03152W109 |
| NUVB | NUVATION BIO INC | 3,031,009 | $5,910 | 0.6% | $11.18 | -81.4% | COM CL A | 67080N101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 136,495 | $5,830 | 0.6% | $44.21 | -21.1% | COM | G31249108 |
| PRME | PRIME MEDICINE INC | 2,074,350 | $5,124 | 0.5% | $14.27 | -89.2% | COM | 74168J101 |
| RAPT | RAPT THERAPEUTICS INC | 630,686 | $5,045 | 0.5% | $7.63 | 0.0% | COM NEW | 75382E208 |
| PEN | PENUMBRA INC | 18,818 | $4,829 | 0.5% | $206.71 | +31.7% | COM | 70975L107 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $4,386 | 0.5% | $32.14 | -97.0% | COM | 82024L103 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $3,410 | 0.4% | $15.04 | -51.5% | COM NEW | 046513206 |
| — | IGM BIOSCIENCES INC | 2,952,131 | $3,306 | 0.4% | $21.94 | — | COM | 449585108 |
| — | LAVA THERAPEUTICS NV | 2,074,372 | $2,738 | 0.3% | $15.19 | — | SHS | N51517105 |
| VTYX | VENTYX BIOSCIENCES INC | 1,114,529 | $2,385 | 0.3% | $2.09 | -22.7% | COM | 92332V107 |
| — | REPARE THERAPEUTICS INC | 1,586,174 | $2,205 | 0.2% | $30.51 | — | COM | 760273102 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 451,099 | $2,107 | 0.2% | $2.16 | +112.1% | COM | 98422E103 |
| PLRX | PLIANT THERAPEUTICS INC | 1,632,577 | $1,894 | 0.2% | $22.82 | -93.8% | COM | 729139105 |
| IVVD | INVIVYD INC | 2,285,320 | $1,634 | 0.2% | $18.61 | -96.2% | COM | 00534A102 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,391,455 | $1,408 | 0.1% | $15.46 | -96.7% | COM | 00166B105 |
| BOLD | BOUNDLESS BIO INC | 589,034 | $595 | 0.1% | $14.25 | -90.7% | COM | 10170A100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 112,168 | $416 | 0.0% | $24.18 | -85.5% | COM | 35104E100 |
| KLRS | KALARIS THERAPEUTICS INC | 82,955 | $221 | 0.0% | $9.79 | -53.9% | COM | 482929106 |